Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 1 1

Status

Completed 3Unknown 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Other 1Head & Neck 1Gastrointestinal 1

Conditions

Neoplasms 2Cancer Cachexia 2Pancreatic Neoplasms 1Mucositis 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
kang-lai-te × Clear all
NCT03101514 2021-06-23

Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

First Affiliated Hospital of Harbin Medical University

Phase 2 Completed
53 enrolled 11 charts
Head & NeckOther

Head and Neck Neoplasms, Neoplasms, Mucositis

NCT03631459 2018-08-21

A Multicenter Real World Study of Kanglaite for Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Unknown
100,000 enrolled

Cancer Cachexia

NCT02553187 2017-02-15

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Phase 4 Unknown
160 enrolled

Cancer Cachexia

NCT00733850 2015-06-19

Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer

KangLaiTe USA

Phase 2 Completed
85 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01640730 2014-01-16

Safety and Exploratory Efficacy of Kanglaite Injection in Non Small Cell Lung Cancer

KangLaiTe USA

Phase 2 Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00031031 2007-11-27

Kanglaite Injection Phase I Study

KangLaiTe USA

Phase 1 Completed
16 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡